跳至主要内容
临床试验/NCT07497737
NCT07497737尚未招募4 期

Osteopathic Manipulative Treatment as an Adjunct Therapy for Adhesive Capsulitis

University Hospitals Cleveland Medical Center3 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2026年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
300
试验地点
3
主要终点
Time to Recovery as Measured in Months

研究概览

简要总结

The goal of this clinical trial is to learn if Osteopathic Manipulative Treatment (OMT) is an effective addition to treatment of adhesive capsulitis. OMT is a non-invasive treatment in which a doctor gently moves and stretches muscles, joints, and tissues manually. Adhesive capsulitis is more commonly known as "frozen shoulder" and describes a shoulder that becomes stiff, painful, and limited in its motion due to some structural change in the joint. The main questions it aims to answer are:

Is recovery faster when OMT is added to regular treatment? Are patients that underwent OMT more satisfied with their treatment?

Researchers will compare patients who underwent OMT to patients who did not to see if OMT is an effective additional treatment for frozen shoulder.

Participants will:

  • Be assigned to one of the four experimental groups
  • Visit clinic and/or physical therapy to undergo the treatments associated with their group:
  1. standard course of prescribed physical therapy
  2. standard course of prescribed physical therapy and an injection of an anti-inflammatory and anesthetics in the shoulder
  3. standard course of prescribed physical therapy and (up to) 4 OMT sessions
  4. standard course of prescribed physical therapy, an injection of an anti-inflammatory and anesthetics in the shoulder, and (up to) 4 OMT sessions.
  • Visit clinic 1 month, 3 months, 6 months, and 1 year after treatment is complete
  • Complete a survey about how satisfied they are with their treatment 1 month, 3 months, 6 months, and 1 year after it is complete

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients diagnosed with adhesive capsulitis who have not received prior treatment for it

排除标准

  • patients with contraindications to corticosteroid injections (uncontrolled diabetes, active infection, bleeding disorders, or corticosteroid hypersensitivity)
  • patients diagnosed with adhesive capsulitis who have received (or are currently receiving) treatment for it

研究组 & 干预措施

PT only

No Intervention

Patients in this group will receive the standard treatment for adhesive capsulitis: prescription for physical therapy

PT and OMT

Experimental

Patients in this group will receive (up to) 4 sessions of OMT spaced at least 2 weeks apart in addition to the standard prescription for physical therapy

干预措施: Osteopathic Manipulative Therapy (OMT) (Other)

PT, Injection, and OMT

Experimental

Patients in this group will receive an intra-articular injection consisting of a corticosteroid (methylprednisolone acetate) and anesthetics (Lidocaine and Ropivacaine) and (up to) 4 sessions of OMT in addition to the standard prescription for physical therapy

干预措施: Osteopathic Manipulative Therapy (OMT) (Other)

PT and Injection

Active Comparator

Patients in this group will receive an intra-articular injection consisting of a corticosteroid (methylprednisolone acetate) and anesthetics (Lidocaine and Ropivacaine) in addition to the standard prescription for physical therapy

干预措施: Intra-articular Injection (Drug)

PT, Injection, and OMT

Experimental

Patients in this group will receive an intra-articular injection consisting of a corticosteroid (methylprednisolone acetate) and anesthetics (Lidocaine and Ropivacaine) and (up to) 4 sessions of OMT in addition to the standard prescription for physical therapy

干预措施: Intra-articular Injection (Drug)

结局指标

主要结局

Time to Recovery as Measured in Months

时间窗: Up to 12 months

The number of months separating the initial visit and the final treatment visit. The time taken for the provider to deem further treatment unnecessary

次要结局

  • Change in Range of Motion of the Shoulder Relative to Baseline(Baseline (before treatment) and then 1 month, 3 months, 6 months, and 12 months after treatment has ended)
  • Change in Patient Satisfaction as Measured by Treatment Satisfaction Questionnaire for Medication (TSQM)(Measured 1 month, 3 months, 6 months, and 12 months after the end of treatment.)
  • Change in Pain as Measured by Patient-Reported Pain Score(Measured at baseline (before treatment) then at 3 months, 6 months, and 12 months after treatment has ended.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kevin Killian

Principal Investigator

University Hospitals Cleveland Medical Center

研究点 (3)

Loading locations...

相似试验